Hypothermic Oxygenated Perfusion (HOPE) of Human Liver Grafts

NACompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 30, 2020

Study Completion Date

August 30, 2020

Conditions
Hepatocellular Injury
Interventions
DEVICE

Hypothermic oxygenated perfusion (HOPE)

Application of HOPE for 1 hour, perfusion rate 150-300 ml/min, pressure controlled, perfusion pressure \< 3 mm Hg, perfusion route portal vein, recirculating system, perfusion volume 2 L, perfusate Institute George Lopez solution (IGL-1), perfusate temperature 4-6 °C, perfusate oxygenation 150-200 mm Hg

Trial Locations (2)

8091

University Hospital of Zurich, Zurich

University of Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT01317342 - Hypothermic Oxygenated Perfusion (HOPE) of Human Liver Grafts | Biotech Hunter | Biotech Hunter